African Journal of
Biotechnology

  • Abbreviation: Afr. J. Biotechnol.
  • Language: English
  • ISSN: 1684-5315
  • DOI: 10.5897/AJB
  • Start Year: 2002
  • Published Articles: 12481

Full Length Research Paper

The p53 codon 72 polymorphism and association to prostate cancer in Iranian patients

Abbas Doosti1* and Payam Ghasemi Dehkordi1,2
1Biotechnology Research Center, Islamic Azad University, Shahrekord Branch, Shahrekord, Iran. 2Islamic Azad University, Shahrekord Branch, Young Researchers Club, Shahrekord, Iran.
Email: [email protected]

  •  Accepted: 01 September 2011
  •  Published: 05 October 2011

Abstract

Tp53 is an important tumor suppressor gene, which induces cell growth arrest or apoptosis when subjected to cytotoxic stimuli. Association has been reported between various cancers and p53 codon 72 polymorphism. Our objective was to investigate the possible association between p53 at codon 72 for Arg/ArgArg/Proand Pro/Pro allele polymorphisms in blood samples from 187 prostate cancer patients and 185 controls in southwest Iran by nested-polymerase chain reaction (PCR) of p53 exon 4 and digestion with BstUI restriction enzyme and the DNA fragments were then resolved by electrophoresis in 2% agarose gel. The frequencies of Arg/ArgArg/Pro and Pro/Pro genotypes were 39.57% (74/187),52.41% (98/187) and 8.02% (15/187), respectively, in the cases with prostate cancer, and 27.03% (50/185), 60% (111/185) and 12.97% (24/185), respectively in the healthy controls. Statistically, analyzed and combined results showed there was a significant difference in the frequency of the Arg/Arg genotype and Arg allele between prostate cancer cases and control (p>0.001). These findings suggest thatp53 Arg/Arg genotype could be a risk factor for the development of prostate cancer among patients in southwest Iran.

 

Key words: Prostate cancer, suppressor gene (p53) codon 72, polymorphism, Iran.

Abbreviation

Tp53, Tumor suppressor gene p53; RFLP, restriction fragment length polymorphism.